Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

View source ↗

Summary

This clinical trial update describes a real-world study evaluating quality of life outcomes in adults with advanced Parkinson disease treated with foslevodopa/f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • foslevodopa/foscarbidopa (foslevodopa/foscarbidopa)

Snippet

Sponsor: AbbVie | Conditions: Parkinson Disease | Status: RECRUITING